Health sector themes to watch in 2024
An employee works on the production line of pharmaceutical company Zentiva in Prague, Czech Republic, May 6, 2021. David W. Cerny | Reuters The health-care sector has wiped out much …
Cigna Corp
Stock buying and selling strategies into year end
During the December Monthly Meeting , we took questions directly from Investing Club members. Here are Jim Cramer’s and Director of Portfolio Analysis Jeff Marks’ responses. Their answers have been …
Flying solo without Cigna will keep Humana focused on 2 big priorities in 2024
It looks like Cigna has scrapped its takeover bid for Club holding Humana , removing a dark cloud over both stocks that’s lingered since the acquisition talks surfaced nearly two …
Why investors should trust their homework
Every weekday the CNBC Investing Club with Jim Cramer holds a Morning Meeting livestream at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. 1. U.S. stocks were mixed …
Cigna shares jump on abandoned Humana buyout, buyback plans
Sopa Images | Lightrocket | Getty Images Shares of Cigna jumped Monday following reports that the health-care giant has scrapped its plans to buy rival Humana due to disagreements on …
The top 10 things to watch in the stock market Monday
The top 10 things to watch Monday, Dec. 11 1. U.S. stocks are muted Monday following last week’s push to a new 52-week high in the S & P 500 …
Eli Lilly weight loss drug Zepbound available at U.S. pharmacies
FDA approves Eli Lilly’s Zepbound, a weight loss drug similar to Ozempic and Wegovy Courtesy: Eli Lilly Eli Lilly on Tuesday said its recently approved weight loss treatment Zepbound is …
CVS to change how it prices prescription drugs
A sign outside a CVS Health store in Miami, Aug. 1, 2023. Joe Raedle | Getty Images CVS Health on Tuesday said it will revamp how it prices prescription drugs …
Jim Cramer explains why it’s hard to be bullish on healthcare
CNBC’s Jim Cramer on Thursday told investors why it’s hard to be bullish about healthcare stocks, citing challenges stemming from government action and lack of innovation. “We could really use …
Regulators would never approve it
Jim Cramer urged Humana (HUM) not to pursue a merger with rival health insurer Cigna (CI), questioning the merits of a potential business combination and the likelihood of it passing …